Beyond Triptans: A Review of New Migraine Medications in Clinical Trials
dc.contributor.author | Nakagawa, Christopher | |
dc.contributor.author | Hino Jr., Garret | |
dc.contributor.author | Tokumaru, Sheri | |
dc.contributor.author | Young, Nicole | |
dc.contributor.instructor | Tokumaru, Sheri | |
dc.contributor.instructor | Young, Nicole | |
dc.date.accessioned | 2018-04-06T23:28:24Z | |
dc.date.available | 2018-04-06T23:28:24Z | |
dc.date.issued | 2018-04-06 | |
dc.description | Poster | |
dc.description.abstract | Migraines are a very common and debilitating headache disorder characterized by moderate to severe throbbing headache pain, which can be associated with nausea, vomiting, sensitivity to light and sensitivity to sound.This study is a literature review of recent and ongoing clinical trials for new classes of pharmacologic treatments for acute migraine. | |
dc.format.extent | 1 | |
dc.identifier.uri | http://hdl.handle.net/10790/3449 | |
dc.language.iso | en-US | |
dc.rights | open access | |
dc.subject | Migraine | |
dc.subject | CGRP Blocking Drugs | |
dc.subject | CGRP Targeted Monoclonal Antibodies | |
dc.subject | ALLOD-2 | |
dc.subject | Serotonin 5HT1F Receptor Blockers | |
dc.title | Beyond Triptans: A Review of New Migraine Medications in Clinical Trials | |
dc.type | Presentation | |
dc.type.dcmi | Text |